Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T D Boyer

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Radiology|July 1, 1993
Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapyR D Redvanly, J L Chezmar, R M Strauss, et al.
Gastroenterology|December 28, 1999
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shuntingN Chalasani, W S Clark, L G Martin, et al.
AJR. American Journal of Roentgenology|March 1, 1985
Increased hepatic density and phospholipidosis due to amiodaroneI S Goldman, M L Winkler, S E Raper, et al.
The American Journal of Gastroenterology|November 24, 1999
Predictors of large esophageal varices in patients with cirrhosisN Chalasani, T F Imperiale, A Ismail, et al.
Bone Marrow Transplantation|April 25, 2001
Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantationM W Fried, A Duncan, S Soroka, et al.
Hepatology (Baltimore, Md.)|September 1, 1996
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantationM W Fried, D G Connaghan, S Sharma, et al.
Annals of Surgery|September 1, 1992
Selective shunt in the management of variceal bleeding in the era of liver transplantationJ M Henderson, G T Gilmore, M A Hooks, et al.
Epilepsia|June 15, 1999
Pharmacokinetics of fosphenytoin in patients with hepatic or renal diseaseF T Aweeka, M D Gottwald, J G Gambertoglio, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studiesA J Sanyal, T D Boyer, R T Frederick, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Radiology|July 1, 1993
Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapyR D Redvanly, J L Chezmar, R M Strauss, et al.
Gastroenterology|December 28, 1999
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shuntingN Chalasani, W S Clark, L G Martin, et al.
AJR. American Journal of Roentgenology|March 1, 1985
Increased hepatic density and phospholipidosis due to amiodaroneI S Goldman, M L Winkler, S E Raper, et al.
The American Journal of Gastroenterology|November 24, 1999
Predictors of large esophageal varices in patients with cirrhosisN Chalasani, T F Imperiale, A Ismail, et al.
Bone Marrow Transplantation|April 25, 2001
Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantationM W Fried, A Duncan, S Soroka, et al.
Hepatology (Baltimore, Md.)|September 1, 1996
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantationM W Fried, D G Connaghan, S Sharma, et al.
Annals of Surgery|September 1, 1992
Selective shunt in the management of variceal bleeding in the era of liver transplantationJ M Henderson, G T Gilmore, M A Hooks, et al.
Epilepsia|June 15, 1999
Pharmacokinetics of fosphenytoin in patients with hepatic or renal diseaseF T Aweeka, M D Gottwald, J G Gambertoglio, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studiesA J Sanyal, T D Boyer, R T Frederick, et al.
Pageof 8